Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

CD2_PRIMARY_LYMPHOID_HEMATOPOIETIC_NAS

lymphoma: A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Hospital Discharge: ICD-10 C96

Hospital discharge: ICD-9 202

Hospital discharge: ICD-8 202

Cause of death: ICD-10 C96

Cause of death: ICD-9 202

Cause of death: ICD-8 202

194

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

194

Check minimum number of events None

194

Include endpoints None

194

CD2_PRIMARY_LYMPHOID_HEMATOPOIETIC_NAS

Extra metadata

Level in the ICD hierarchy 3

First used in FinnGen datafreeze DF4

Parent code in ICD-10 C81-C96

Name in latin Neoplasmata maligna alia et non specificata textus lymphatici, haematopoetici et cognati

Similar endpoints

↥

List of similar endpoints to Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

All

Female

Male

Number of individuals

189

105

Unadjusted prevalence (%)

0.06

0.05

0.08

Mean age at first event (years)

51.50

49.48

53.12

?

Follow-up

Amount of time to look for the endpoint since entering the study. This is either either 1, 5, 15 years or the full study time from 1998 to 2019.

Absolute risk

Estimates the probability of dying from the current endpoint. Check the Documentation page for Mortality: absolute risk to get more details.

Hazard Ratio (HR) and 95% Confidence Interval (CI)

Measures how much the risk of dying increases (HR > 1) or decreases (HR < 1).

Number of individuals (N)

Number of individuals having the current endpoint and died during the follow-up time.
Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: CD2_PRIMARY_LYMPHOID_HEMATOPOIETIC_NAS – Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
GWS hits: 0

Survival analyses between endpoints

↥

Plot

before Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
after Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

↥